Borrebaeck C - Search Results

1

Genomic allergen rapid detection in-house validation--a proof of concept.

Johansson H, Rydnert F, Kühnl J, Schepky A, Borrebaeck C, Lindstedt M. Johansson H, et al. Among authors: borrebaeck c. Toxicol Sci. 2014 Jun;139(2):362-70. doi: 10.1093/toxsci/kfu046. Epub 2014 Mar 27. Toxicol Sci. 2014. PMID: 24675087

2

A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.

Johansson H, Lindstedt M, Albrekt AS, Borrebaeck CA. Johansson H, et al. BMC Genomics. 2011 Aug 8;12:399. doi: 10.1186/1471-2164-12-399. BMC Genomics. 2011. PMID: 21824406 Free PMC article.

3

The GARD assay for assessment of chemical skin sensitizers.

Johansson H, Albrekt AS, Borrebaeck CA, Lindstedt M. Johansson H, et al. Toxicol In Vitro. 2013 Apr;27(3):1163-9. doi: 10.1016/j.tiv.2012.05.019. Epub 2012 Sep 29. Toxicol In Vitro. 2013. PMID: 23032079 Free article.

4

Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.

Albrekt AS, Johansson H, Börje A, Borrebaeck C, Lindstedt M. Albrekt AS, et al. Among authors: borrebaeck c. BMC Pharmacol Toxicol. 2014 Feb 11;15:5. doi: 10.1186/2050-6511-15-5. BMC Pharmacol Toxicol. 2014. PMID: 24517095 Free PMC article.

5

Evaluation of the GARD assay in a blind Cosmetics Europe study.

Johansson H, Gradin R, Forreryd A, Agemark M, Zeller K, Johansson A, Larne O, van Vliet E, Borrebaeck C, Lindstedt M. Johansson H, et al. Among authors: borrebaeck c. ALTEX. 2017;34(4):515-523. doi: 10.14573/altex.1701121. Epub 2017 Feb 17. ALTEX. 2017. PMID: 28214915 Free article.

6

Histamine H(4) receptor antagonism inhibits allergen-specific T-cell responses mediated by human dendritic cells.

Lundberg K, Broos S, Greiff L, Borrebaeck CA, Lindstedt M. Lundberg K, et al. Eur J Pharmacol. 2011 Jan 25;651(1-3):197-204. doi: 10.1016/j.ejphar.2010.10.065. Epub 2010 Nov 18. Eur J Pharmacol. 2011. PMID: 21093429

7

Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.

Forreryd A, Johansson H, Albrekt AS, Borrebaeck CA, Lindstedt M. Forreryd A, et al. PLoS One. 2015 Mar 11;10(3):e0118808. doi: 10.1371/journal.pone.0118808. eCollection 2015. PLoS One. 2015. PMID: 25760038 Free PMC article.

8

Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells.

Larsson K, Lindstedt M, Borrebaeck CA. Larsson K, et al. Immunology. 2006 Feb;117(2):156-66. doi: 10.1111/j.1365-2567.2005.02274.x. Immunology. 2006. PMID: 16423051 Free PMC article.

9

Pattern rules: biomarker signatures for sensitization as an alternative to animal testing.

Lindstedt M, Borrebaeck C. Lindstedt M, et al. Among authors: borrebaeck c. Biomark Med. 2011 Dec;5(6):809-11. doi: 10.2217/bmm.11.82. Biomark Med. 2011. PMID: 22103614 No abstract available.

10

Augmented Phl p 5-specific Th2 response after exposure of dendritic cells to allergen in complex with specific IgE compared to IgG1 and IgG4.

Lundberg K, Lindstedt M, Larsson K, Dexlin L, Wingren C, Ohlin M, Greiff L, Borrebaeck CA. Lundberg K, et al. Among authors: borrebaeck ca. Clin Immunol. 2008 Sep;128(3):358-65. doi: 10.1016/j.clim.2008.04.011. Epub 2008 Jun 26. Clin Immunol. 2008. PMID: 18583195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page